31![Canadian Adverse Reaction Newsletter Volume 23 • Issue 2 • April 2013 www.health.gc.ca/carn In this issue Intraocular lenses and the Canadian Adverse Reaction Newsletter Volume 23 • Issue 2 • April 2013 www.health.gc.ca/carn In this issue Intraocular lenses and the](https://www.pdfsearch.io/img/7d3ab4963cad192e635b9dbab324906f.jpg) | Add to Reading ListSource URL: hc-sc.gc.caLanguage: English - Date: 2013-06-24 11:45:03
|
---|
32![Did you know blood glucose monitoring in individuals with type 2 diabetes NOT on insulin will vary depending on an individual’s unique situation? Purposeful blood glucose monitoring is the recommended way to improve di Did you know blood glucose monitoring in individuals with type 2 diabetes NOT on insulin will vary depending on an individual’s unique situation? Purposeful blood glucose monitoring is the recommended way to improve di](https://www.pdfsearch.io/img/fe169582b1029a0afc3ee115915090ae.jpg) | Add to Reading ListSource URL: www.gnb.caLanguage: English - Date: 2013-04-08 13:20:20
|
---|
33![STATE OF MICHIGAN DEPARTMENT OF ENERGY, LABOR & ECONOMIC GROWTH OFFICE OF FINANCIAL AND INSURANCE REGULATION Before the Commissioner of Financial and Insurance Regulation In the matter of STATE OF MICHIGAN DEPARTMENT OF ENERGY, LABOR & ECONOMIC GROWTH OFFICE OF FINANCIAL AND INSURANCE REGULATION Before the Commissioner of Financial and Insurance Regulation In the matter of](https://www.pdfsearch.io/img/d593ce39b9a913114d73a2514ff8ffed.jpg) | Add to Reading ListSource URL: www.michigan.govLanguage: English - Date: 2012-12-07 20:40:37
|
---|
34![TO: Maine Drug Utilization Review Board DATE: October 14, 2013 RE: Maine DUR Board Meeting minutes from October 8, 2013 ATTENDANCE TO: Maine Drug Utilization Review Board DATE: October 14, 2013 RE: Maine DUR Board Meeting minutes from October 8, 2013 ATTENDANCE](https://www.pdfsearch.io/img/dae99e92c2b2e860c6dcb79812235ccf.jpg) | Add to Reading ListSource URL: mainecarepdl.orgLanguage: English - Date: 2013-11-22 11:08:54
|
---|
35![U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may](https://www.pdfsearch.io/img/7156701a77490cc20b6a9bf3c6ebf3c3.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
36![U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may](https://www.pdfsearch.io/img/e3a620ddb5ae6c0469fb239817a186ce.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
37![Report on the Deliberation Results May 31, 2013 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare [Brand name] Lyxumia Subcutaneous Injection 300 μg Report on the Deliberation Results May 31, 2013 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare [Brand name] Lyxumia Subcutaneous Injection 300 μg](https://www.pdfsearch.io/img/4ac77dd5d2a7b27e1329f2fd351a78b7.jpg) | Add to Reading ListSource URL: www.pmda.go.jpLanguage: English - Date: 2014-03-13 00:40:49
|
---|
38![Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed] Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]](https://www.pdfsearch.io/img/aaea5f9f2c026e478c3b57f533318315.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2013-07-02 08:41:50
|
---|
39![TO: Maine Drug Utilization Review Board DATE: October 14, 2013 RE: Maine DUR Board Meeting minutes from October 8, 2013 ATTENDANCE TO: Maine Drug Utilization Review Board DATE: October 14, 2013 RE: Maine DUR Board Meeting minutes from October 8, 2013 ATTENDANCE](https://www.pdfsearch.io/img/19e3d9b311f615baaf4884ce9d2238f4.jpg) | Add to Reading ListSource URL: www.mainecarepdl.orgLanguage: English - Date: 2013-11-22 11:08:54
|
---|
40![What’s “hot” about thermogenic agents What’s “hot” about thermogenic agents](https://www.pdfsearch.io/img/dcb3d9dda1121d4fa16dc7c7e0fb4d61.jpg) | Add to Reading ListSource URL: dpic.orgLanguage: English - Date: 2013-06-09 23:17:15
|
---|